60
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Diagnostic value of angiopoietin-like protein 2 for CHB-related hepatocellular carcinoma

, , , , , , , & show all
Pages 7159-7169 | Published online: 29 Jul 2019

References

  • Yang JD, Roberts LR. Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol. 2010;7(8):448–458. doi:10.1038/nrgastro.2010.10020628345
  • Villanueva A. Hepatocellular carcinoma. N Engl J Med. 2019;380(15):1450–1462. doi:10.1056/NEJMra171326330970190
  • Wang FS, Fan JG, Zhang Z, et al. The global burden of liver disease: the major impact of China. Hepatology. 2014;60(6):2099–2108. doi:10.1002/hep.2740625164003
  • Farrell GC, Chan HL, Yuen MF ,et al. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements. J Gastroenterol Hepatol. 2010;25(4):657–663. doi:10.1111/j.1440-1746.2009.06167.x20492323
  • Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53(3):1020–1022. doi:10.1002/hep.2419921374666
  • Llovet JM, Ducreux M, Lencioni R ,et al.EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56(4):908–943. doi:10.1016/j.jhep.2011.12.00122424438
  • Farinati F, Marino D, De Giorgio M, et al. Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither? Am J Gastroenterol. 2006;101(3):524–532. doi:10.1111/j.1572-0241.2006.00443.x16542289
  • Carbone C, Piro G, Merz V, et al. Angiopoietin-like proteins in angiogenesis, inflammation and cancer. Int J Mol Sci. 2018;19(2):431. doi:10.3390/ijms19020431
  • Gao L, Ge C, Fang T, et al. ANGPTL2 promotes tumor metastasis in hepatocellular carcinoma. J Gastroenterol Hepatol. 2015;30(2):396–404. doi:10.1111/jgh.1270225090954
  • Deng Y, Zhao H, Zhou J, et al. Angiopoietin-like protein as a novel marker for liver fibrosis in chronic hepatitis B patients with normal to minimally raised ALT. BMC Infect Dis. 2017;17(1):650. doi:10.1186/s12879-017-2757-228962551
  • Zhou J, Song L, Zhao H, et al. Serum hepatitis B core antibody as a biomarker of hepatic inflammation in chronic hepatitis B patients with normal alanine aminotransferase. Sci Rep. 2017;7(1):2747. doi:10.1038/s41598-017-03102-328584279
  • Cong WM, Hu XQ, Sun YT, et al. Expert consensus on the scheme of pathological diagnosis of primary liver cancer. Chin Clin Oncol. 2012;1(1):12.25842070
  • Jia W, Song LW, Fang YQ, et al. Antibody to hepatitis B core antigen levels in the natural history of chronic hepatitis B: a prospective observational study. Medicine. 2014;93(29):e322. doi:10.1097/MD.000000000000032225546679
  • Teicher BA. Searching for molecular targets in sarcoma. Biochem Pharmacol. 2012;84(1):1–10. doi:10.1016/j.bcp.2012.02.00922387046
  • Aoi J, Endo M, Kadomatsu T, et al. Angiopoietin-like protein 2 is an important facilitator of inflammatory carcinogenesis and metastasis. Cancer Res. 2011;71(24):7502–7512. doi:10.1158/0008-5472.CAN-11-175822042794
  • Toiyama Y, Inoue Y, Shimura T, et al. Serum angiopoietin-like protein 2 improves preoperative detection of lymph node metastasis in colorectal cancer. Anticancer Res. 2015;35(5):2849–2856.25964566
  • Benson AB 3rd, D’Angelica MI, Abbott DE, et al. NCCN guidelines insights: hepatobiliary cancers, version 1.2017. J Natl Compr Canc Netw. 2017;15(5):563–573.28476736
  • Roberts LR, Sirlin CB, Zaiem F, et al. Imaging for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis. Hepatology. 2018;67(1):401–421. doi:10.1002/hep.2948728859233
  • Luo P, Wu S, Yu Y, et al. Current status and perspective biomarkers in AFP negative HCC: towards screening for and diagnosing hepatocellular carcinoma at an earlier stage. Pathol Oncol Res. 2019. doi:10.1007/s12253-019-00585-5
  • Zheng J, Umikawa M, Cui C, et al. Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development. Nature. 2012;485(7400):656–660. doi:10.1038/nature1109522660330
  • Carbone C, Piro G, Fassan M, et al. An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis. Oncotarget. 2015;6(15):13822–13834. doi:10.18632/oncotarget.263525360865
  • Liu X, Yu X, Xie J, et al. ANGPTL2/LILRB2 signaling promotes the propagation of lung cancer cells. Oncotarget. 2015;6(25):21004–21015. doi:10.18632/oncotarget.421726056041
  • Li X, Wei X, Xu H, et al. Expression of leukocyte immunoglobulin-like receptor B2 in hepatocellular carcinoma and its clinical significance. J Cancer Res Ther. 2018;14(7):1655–1659. doi:10.4103/jcrt.JCRT_542_1830589055